Metro Healthcare Indonesia (CARE) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.11x

Metro Healthcare Indonesia (CARE) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting Rp1.77 Billion (capex Rp1.77 Billion ) from operating cash flow of Rp16.50 Billion. Check Metro Healthcare Indonesia (CARE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.11x

(Capex + Investments) / Operating CF

Total Reinvested

Rp1.77 Billion

Capex + Investments

Operating Cash Flow

Rp16.50 Billion

IDR

Capital Expenditures

Rp1.77 Billion

IDR

Metro Healthcare Indonesia Cash Flow Reinvestment Rate (2020–2021)

Historical reinvestment intensity for Metro Healthcare Indonesia across 2 annual periods. Explore Metro Healthcare Indonesia (CARE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Metro Healthcare Indonesia (2020–2021)

Year-by-year capital reinvestment analysis for Metro Healthcare Indonesia. For live market cap and broader valuation context, see Metro Healthcare Indonesia market capitalisation.

Year	Reinvestment Rate	Total Reinvested (IDR)	Operating CF	Capex	YoY Change
2021	16.13x	Rp760.40 Billion	Rp47.13 Billion	Rp310.40 Billion	▲ +49.7%
2020	10.78x	Rp542.27 Billion	Rp50.30 Billion	Rp522.27 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow